The weekly litigation news digest is live. Subscribe now

IP Verse

Glp-1 Receptor Agonists And Uses Thereof - EP3555064

The patent EP3555064 was granted to Pfizer on Mar 1, 2023. The application was filed on Dec 1, 2017 under application number EP17817174A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3555064

PFIZER
Application Number
EP17817174A
Filing Date
Dec 1, 2017
Status
Granted And Under Opposition
Oct 21, 2022
Publication Date
Mar 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MARGARET DIXONAug 23, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS3773919
DESCRIPTIONUS4485045
DESCRIPTIONUS4544545
DESCRIPTIONUS5013556
DESCRIPTIONWO2010022055
INTERNATIONAL-SEARCH-REPORTUS2004127504
INTERNATIONAL-SEARCH-REPORTWO2011143365
OPPOSITIONUS2003162790
OPPOSITIONUS2004127504
OPPOSITIONUS2008280933
OPPOSITIONUS2012028959
OPPOSITIONUS5714498
OPPOSITIONUS5780475
OPPOSITIONWO2011143365

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents